Viewing Study NCT05050032


Ignite Creation Date: 2025-12-24 @ 9:36 PM
Ignite Modification Date: 2025-12-31 @ 2:01 AM
Study NCT ID: NCT05050032
Status: COMPLETED
Last Update Posted: 2022-06-15
First Post: 2021-09-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Relationship Between Superior Vena Cava Flow and Intraventricular Hemorrhage in Preterm Infants
Sponsor: Marwa Mohamed Farag
Organization:

Study Overview

Official Title: Study to Assess the Relationship Between Superior Vena Cava Flow and Intraventricular Hemorrhage in Preterm Infants
Status: COMPLETED
Status Verified Date: 2022-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of the study was to evaluate the relationship between superior vena cava (SVC) flow measurements within the first 24 hours of life and development of intraventricular hemorrhage in preterm born infants.
Detailed Description: A prospective, observational cohort study was carried out on newborns that fulfill the eligibility criteria and delivered at the Alexandria University Maternity Hospital (AUMH).

The Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital with total admissions of approximately 2100 newborn per year of which approximately more than 50% are admitted due to prematurity and its complications.

The study was carried out in 3 phases:

1. First phase: Enrollment and selection phase.
2. Second phase: Monitoring and Evaluation phase.
3. Third phase: Statistical analysis of the data

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: